To explain the above inconsistent results, a meta‐analysis including 3,406 cases and 5,147 controls was conducted, and five genetic models were utilized to assess the association between the EGLN2 rs10680577 polymorphism and cancer risk. The gene discussed is EGLN2; the disease is cancer.